
Rhythm Pharma’s drug for rare obesity meets late-stage trial goal
Audio By Carbonatix By Sneha S K and Siddhi Mahatole (Reuters) -Rhythm Pharmaceuticals said on Monday its drug Imcivree notably reduced weight in patients with a rare obesity disorder caused by damage to the brain, meeting the main goal of a late-stage …